GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Total Debt per Share

BioHarvest Sciences (XCNQ:BHSC) Total Debt per Share : C$0.82 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Total Debt per Share?

C$0.82 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. BioHarvest Sciences's Total Debt Per Share for the quarter that ended in Jun. 2024 was C$0.82.

BioHarvest Sciences Total Debt per Share Historical Data

The historical data trend for BioHarvest Sciences's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Total Debt per Share Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.26 0.26 1.09 2.19

BioHarvest Sciences Quarterly Data
Jul19 Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.13 2.19 0.75 0.82

BioHarvest Sciences Total Debt per Share Calculation

BioHarvest Sciences's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1.91+28.06)/13.68
=2.19

BioHarvest Sciences's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(12.64+1.60)/17.33
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Total Debt per Share Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Total Debt per Share
Comparable Companies
TSXV:FRSH XCNQ:BOIL TSX:SWP TSX:BABY XCNQ:MOOO XCNQ:HBFG XCNQ:BITE TSX:BU NEOE:NGRB XCNQ:GFCO XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
CNVCD:USA 8MV0:Germany
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
Website
https://www.bioharvest.com
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences Headlines

No Headlines